chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; felt "little tired"; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), FATIGUE (felt "little tired"), CHILLS (chills), HEADACHE (headache) and FATIGUE (fatigue),in right eye "blinding white aura for 15 minutes",seems like migraine lost vision" in right eye, in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 016B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse events were reported).   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced HEADACHE (Headache), FATIGUE (felt "little tired") and CHILLS (chills). On 27-Mar-2021, the patient experienced HEADACHE (headache) and FATIGUE (fatigue). The patient was treated with IBUPROFEN for Migraine, at an unspecified dose and frequency. On 28-Feb-2021, HEADACHE (Headache) and FATIGUE (felt "little tired") had resolved. On 28-Mar-2021, HEADACHE (headache) and FATIGUE (fatigue) had resolved. At the time of the report, CHILLS (chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-061190 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-061190:Dose 2
flu like symptoms; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (sore arm). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (sore arm) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: No specific follow-up information recorded.
RED PIN LIKE DOTS UNDER SKIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced red pin like dots under skin. The action taken with covid-19 vaccine was not applicable. The outcome of red pin like dots under skin was not reported. This report was non-serious.
This case was reported by a nurse via sales rep and described the occurrence of vaccination failure in a patient who received DTaP vaccine. On an unknown date, the patient received DTaP vaccine at an unknown dose. On an unknown date, unknown after receiving DTaP vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and cough. On an unknown date, the outcome of the vaccination failure and cough were unknown. It was unknown if the reporter considered the vaccination failure and cough to be related to DTaP vaccine. Additional details were reported as follows: The reporter stated that, the patient had all been  vaccinated. The patient was tested positive, but had no symptoms to minimum symptoms with less coughing. When tested, the patient was pertactin lacking. The reporter was not sure which brand of DTap that was administered to the patient. This is one of the 5 cases, reported by the same reporter.
Post vax child developed rash approximately one hour later. States welts on tummy and face. Rash on body, moderate febrile temp was controlled with Tylenol.
pt recv vax 2JUL98 & devel severe flu-like sx on 3JUL98;pt hosp;relevant physical findings, labdata & test results include several blood tests while in hosp & lung & kidney biopsy d/t underlying other problems;dx pneumonia;
2nd Dose: May 14 - severe muscle spasm in back beginning at 8pm, fever of 101, muscle aches and joint pain throughout entire body, headache, fogginess in head, blurred vision in right eye, nasal congestion, bleeding nose, tickle cough, lightheadedness
PATIENT ACCIDENTLY GOT TWO MODERNA BIVALENT DOSES INSTEAD OF ONE WITH SEASONAL INFLUENZA VACCINE.
SHORTNESS OF BREATH; PARAESTHESIA; CANNOT STAND; HYPOAESTHESIA; This spontaneous report received from a parent concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination on left deltoid. No concomitant medications were reported. On 24-MAR-2021, the subject experienced shortness of breath. On 24-MAR-2021, the subject experienced Paraesthesia. On 24-MAR-2021, the subject experienced cannot stand. On 24-MAR-2021, the subject experienced Hypoaesthesia. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from shortness of breath, Paraesthesia, and Hypoaesthesia, and the outcome of cannot stand was not reported. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
Information has been received from a nurse concerning a 13 year old female who on 14-AUG-2007 was vaccinated with a first dose of Gardasil (658094/0524U). Concomitant vaccination given on the same day included BOOSTRIX and MENACTRA. On 14-AUG-2007 the patient experienced syncope. Unspecified medical attention was sought. On 14-AUg-2007 the patient recovered. Additional information has been requested.
nearly died yesterday; itching all over my body especially in my throat, around my throat; itching all over my body especially in my throat, around my throat; Coughing; Runny nose; Headache; Nausea; throat closed up; Allergic reaction; This is a spontaneous report from a contactable consumer. A 41-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: EW0183) via an unspecified route of administration, administered in Arm Left on 2021 as Dose Number Unknown, Single for covid-19 immunisation; hydrochlorothiazid (HYDROCHLOROTHIAZID), route of administration, start and stop date, batch/lot number and dose were not reported for blood pressure abnormal. Medical history included blood pressure abnormal and stress. The patient's concomitant medication included vitamin. It was reported that, patient had a reaction to the vaccine on an unspecified date. It was reported that patient had to go to the urgent care yesterday and also spoke with his doctor patient had throat closed up and had itching all over body especially in the throat and around the throat. There was some coughing, runny nose, headache, nausea that was the most severe reaction patient had. The patient received treatment of Steroids Benadryl. Steroids and Benadryl were given by IM. Reporter further stated, that he nearly died yesterday (27Aug2021). Therapeutic measures were taken as a result of events. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
vision right eye/left eye became little blurry; pain behind the right eye/left eye; losing vision in right eye; hurt behind the eyes; seeing double at a distance; excruciating headache; puking/vomiting; This spontaneous case was reported by a consumer and describes the occurrence of BLINDNESS (losing vision in right eye) and SCLERITIS (hurt behind the eyes) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included IBUPROFEN for Back pain, ACICLOVIR SODIUM (ACYCLOVIR) for Cold.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 31-Mar-2021, the patient experienced HEADACHE (excruciating headache) and VOMITING (puking/vomiting). On 06-Apr-2021, the patient experienced SCLERITIS (hurt behind the eyes) (seriousness criterion medically significant) and DIPLOPIA (seeing double at a distance). On an unknown date, the patient experienced BLINDNESS (losing vision in right eye) (seriousness criterion medically significant), VISION BLURRED (vision right eye/left eye became little blurry) and EYE PAIN (pain behind the right eye/left eye). At the time of the report, BLINDNESS (losing vision in right eye), SCLERITIS (hurt behind the eyes), EYE PAIN (pain behind the right eye/left eye), DIPLOPIA (seeing double at a distance), HEADACHE (excruciating headache) and VOMITING (puking/vomiting) outcome was unknown and VISION BLURRED (vision right eye/left eye became little blurry) had not resolved.            Treatment medication was not reported.  Very limited information regarding these events has been provided at this time. Further information has been requested.   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: No specific follow-up information recorded.; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested.
I woke up the morning on the day after receiving the shot. I felt achy, tired, and had the shakes to the point where I called in sick from work. I was better the next day (two days after receiving the shot).  The injection point on my left arm was very sore and got worse over the next day. I'm writing this 4 days later and there is still discomfort at the injection site.
Got vaccine at 930am. Woke up morning after the vaccine about 930am with tingling/severe pain shoulders and all of back/torso, legs ached. During shower at that time, very close to vomiting/passing out. Took NSAID and slept.  Then tylenol mid day. That evening had fatigue and pain all over, slight head ache, chills and then turned to temp 99.9, very warm/uncomfortable. Tylenol again. Woke on Sunday better just fatigue and achy.
Extreme sensitivity to caffeine, body rashes and severe itchiness. Palpitations and skin crawling
Pt started getting a bumpy rash on both arms the Sunday after receiving vaccine.  It is very itchy.  Pt has been applying hydrocortisone with minimal relief of itching.   Also recommended pt take oral antihistamine.   Pt denies exposure to topical allergens i.e. poison ivy.
Patient was given incorrect volume of Havrix. Patient was given 1ml instead of 0.5ml.
Sick; Tested positive for flu / Had the flu; This spontaneous case was reported by a patient family member or friend and describes the occurrence of ILLNESS (Sick) and INFLUENZA (Tested positive for flu / Had the flu) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick) and INFLUENZA (Tested positive for flu / Had the flu). At the time of the report, ILLNESS (Sick) and INFLUENZA (Tested positive for flu / Had the flu) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Influenza virus test: positive (Positive) Positive.     The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medication was reported.   It was reported that cold viruses were in patient's home and had lot of problems in the family.    No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-596527 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-596527:MOD22-017437, Reporter's case
sore throat; runny nose; This is a spontaneous report from a contactable consumer (reported for herself) from a Pfizer-sponsored program. A 48-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 04Jan2021 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient experienced runny nose on 20Jan2021 and had sore throat on 21Jan2021. Patient took 1st dose of covid vaccine on 04Jan2021, supposed to get 2nd one on 25Jan2021, but patient have a runny nose that started last Wednesday (20Jan2021) and sore throat on 21Jan2021. Patient asked if the second dose must be 3 weeks exactly, or can she take it later. Patient also asked for the timing of the second dose of Pfizer-BioNTech COVID-19 vaccine and if she could receive it earlier or later than 3 weeks. The events were reported as not serious. The outcome of the events runny nose and sore throat was unknown.   Information on the Batch/Lot number has been requested.
This spontaneous report as received from a company representative refers to a male patient of unknown age. On 29-MAY-2018 the patient was vaccinated with PNEUMOVAX 23 for prophylaxis. On 30-MAY-2018, 2 days after onset of therapy the patient experienced feeling abnormal. The outcome of feeling abnormal was reported as not recovered/not resolved.
about two inches around the site was red and outlined. Felt slightly raised and was itching. Is still red today 1/4/21
Yesterday,: Started red, hot, itchy, then noticed a raised bump, more rigid than soft. Looked more like a bruise, color was purplish red.  About an hour later, bump was growing,, like a goose egg when you hit your head. I could feel my skin stretching, heat and itchy increased.  Took a single Benadryl, applied ice pack. Ice pack was effective in turning down the heat.  Today, more purple, still rigid bump about the shape of a goose egg. Raised level, maybe half an inch or so.
After patient's Wellness check up on 8/01/16, about an hour later after his Polio, HIB, HEP B and PneumoConju shots done same day on 8/01/16, patient started having high fever and had 2 back to back convulsions, seizures. We rushed to the ER where he was kept overnight until next evening.
Second dose not administered; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in April 2021, batch number: 9T355 expiry date: 11-SEP-2022).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.       Additional Information: GSK Receipt Date: 19-Jul-2022 Reporter's Comments: Pharmacy intern reported that female patient received the first dose of Shingrix and second dose was not administered. The reporter consented to follow up. The vaccine administration facility was the same as primary reporter. The VAERS details provided for 1st dose. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
This spontaneous report was received from a licensed practical nurse and refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical histories, drug reactions or allergies and concomitant medications were not reported. On unspecified dates in November 2016 (reported as since 05-NOV-2016) the patients were vaccinated with doses of improperly stored ROTATEQ orally, lot # M004542, expiration date 18-OCT-2017, lot # L046320, expiration date 29-SEP-2017 (dose was not reported). No adverse experience was reported. Product quality complaint was not involved. The administered doses of ROTATEQ were stored in the temperature of 14.6 degrees Celsius for 62 hours. There was no previous temperature excursion. Data logger was involved. This is one of two reports received from the same reporter. Additional information has been requested.
She got her vaccine, they did not make her wait, told her she was OK to leave.  She had burning within seconds of the vaccine.  Then about 7 minutes later her arm was getting numb and her neck got stiff, which freaked her out, the back of her neck and to her shoulder blade and shoulder area.  Her right arm also was hurting.  She pulled over, waited about 10 minutes or so and drove home which took 10 minutes.  She looked at it and thought it wasn't good, took 2 Tylenol and it was hot.  She put a clean cool cloth on it directly and then after that she rinsed it out, got a clean baggy and put back in the baggy and put that on it to keep it moist.  She fell asleep at 7:00 PM.  She woke up at 1:30 AM and her whole body felt like it was on fire, although she did not have a temp.  She did have some chills, had the back door open, her nose was running, her eyes were pouring, and had a cough.  She had some eye drops, put that in her eyes, didn't know if it worked or not as it burns. Then she put regular Tears by Refresh in her eyes as well.  This morning she woke and feels terrible, her arm and shoulder.  She took some Tylenol this morning, does not feel as congested, but is sneezing.
devel rash c/w erythema multiforme 16MAR97 w/steady progression over several days;joint pain & swelling by 18MAR97 along w/angioedema;fever from 16MAR;findings c/w serum sickness-like rxn;also had red pharynx;strep negative;
Information has been received from a physician concerning a 17 year old female who was vaccinated on an unspecified date with her first dose of Gardasil.  Subsequently the patient experienced abdominal pain that lasted 3-4 days.  Subsequently, the patient recovered from the abdominal pain.  The patient received the second dose of Gardasil on an unspecified date and told the physician she had abdominal pain again.  The patient recovered on an unspecified date.  The physician was not sure if the patient really had pain or if it was psychological.  The patient had not decided yet whether or not she will received the third dose.  She sought unspecified medical attention.  Additional information has been requested.
I felt lightheaded after receiving the vaccine with very little energy for two days. I work up on 11/26/2022 with a sore throat and I felt worse as the day progressed. I tested positive with a home test for COVID-19 on 11/26/2022. I got the prescription for PAXLOVID, but I did not take it. I took acetaminophen to help with my symptoms. I continue to feel run down as of today.
Pt stated 2 days after vaccine  she had left arm, face, and head  tingling. Pt was able to walk, no weakness. Site of injection left deltoid was tender to touch.  Pt was referred to ER for further assessment. Pending outcome.
Migraine; period started 2 days early the day after the shot and slightly heavier bleeding than usual.; Headache; Fatigue; Mild fever of 99.9; Tenderness of lymph node under left arm; swelling and tenderness of lymph node; This is a spontaneous report received from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in left arm on 22Apr2021 at 11:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medications included ZYRTEC and PRILOSEC for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in left arm on 01Apr2021 at 10:45 (at the age of 48-years-old) as a single dose, for COVID-19 immunisation. On 23Apr2021 the body temperature was measured and was found to be 99.9 (unspecified unit). On 23Apr2021 at 07:00 the patient experienced mild fever of 99.9 (unspecified unit), fatigue, swelling, tenderness of lymph node under left arm (lymph node tenderness) and headache. On the same day the patient also reported that period started 2 days early the day after the shot and slightly heavier bleeding (bleeding menstrual heavy) than usual. On 25Apr2021 3 days after the shot the patient had experienced migraine. The clinical outcome of events lymph node tenderness, swelling, bleeding menstrual heavy, headache, pyrexia, fatigue was recovered on an unspecified date in Apr2021; while that of the event migraine was unknown.   No follow-up attempts are needed. No further information is expected.
july, 2006, began regressing in speech, and did not want anything to do with family and friends.  mom states big for age.  does not talk a lot and vocabulary has decreased to 10 - 15 words.
Second vaccine fever and frequent urination and jittery feeling; Second vaccine fever and frequent urination and jittery feeling; Second vaccine fever and frequent urination and jittery feeling; This is a spontaneous report received from a contactable consumer (Patient). A 57-year-old female patient (not pregnant) received bnt162b2 (Pfizer-BioNTech Covid-19 Vaccine), dose 2 via an unspecified route of administration, administered in Arm Left on 30Mar2021 11:00 (Lot Number: ER8737) at single dose for covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered was Public Health Clinic. Medical history was none, no allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included colecalciferol (VITAMIN D 3) taken for an unspecified indication, start and stop date were not reported; biotin taken for an unspecified indication, start and stop date were not reported. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of bnt162b2 (lot number: EN6206) on 08Mar2021 04:00 PM for covid-19 immunization and experienced sore arm. The patient experienced second vaccine fever and frequent urination and jittery feeling on 31Mar2021 12:00. Since the vaccination, the patient had not been tested for COVID-19. No treatment was received for the events. The outcome of the events was not recovered. Seriousness criteria was no.  No follow-up attempts are needed. No further information is expected.
Patient felt dizzy during 15 minute wait time after given Janssen COVID19 vaccination and wanted to lay down on the floor but stressed that she was fine and just needed some water. Patient was not feeling better after 15 minutes so 911 was called at  4:59PM and a member of management was called for a Code White to report to the pharmacy. The Rescue Squad arrived at 5:08PM and started to assess the patient. BP: 100/70 and BG: 113. Patient states that this has happened before but not after a vaccination. All vitals were normal but patient was still fainting in an out, Emergency Squad recommended patient and husband to go to the hospital for further observation.